These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 7121431)

  • 41. Clinical and biological studies in 14 cases of Prader-Labhart Willi syndrome.
    Thompson EM
    J Genet Hum; 1989 Dec; 37(4-5):439. PubMed ID: 2635721
    [No Abstract]   [Full Text] [Related]  

  • 42. Induction of menarche by clomiphene citrate in a fifteen-year-old girl with the Prader-Labhart-Willi syndrome.
    Linde R; McNeil L; Rabin D
    Fertil Steril; 1982 Jan; 37(1):118-20. PubMed ID: 7037461
    [No Abstract]   [Full Text] [Related]  

  • 43. [The hypotonia-hypomentia-hypogonadism-obesity syndrome (Prader-Willi-Labhart syndrome) in a 38-year-old man].
    van Bergeijk L; van der Veen EA
    Ned Tijdschr Geneeskd; 1980 Dec; 124(49):2090-2. PubMed ID: 7442851
    [No Abstract]   [Full Text] [Related]  

  • 44. Disappearance of a urinary antigonadotrophin following HCG administration in Prader Willi syndrome.
    Harris JC; Knigge KM
    Prog Clin Biol Res; 1982; 92():273-82. PubMed ID: 7051039
    [No Abstract]   [Full Text] [Related]  

  • 45. Growth hormone treatment of patients with Prader-Willi syndrome. Swedish Growth Hormone Advisory Group.
    Ritzén EM; Lindgren AC; Hagenäs L; Marcus C; Müller J; Blichfeldt S
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():345-9. PubMed ID: 10698600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Using stable isotopes to assess reduced physical activity of individuals with Prader-Willi syndrome.
    Davies PS; Joughin C
    Am J Ment Retard; 1993 Nov; 98(3):349-53. PubMed ID: 8292311
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Premature adrenarche, increased growth velocity and accelerated bone age in male patients with Prader-Labhart-Willi syndrome.
    Schmidt H; Schwarz HP
    Eur J Pediatr; 2001 Jan; 160(1):69-70. PubMed ID: 11195029
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Management of obesity in Prader-Willi syndrome.
    Butler MG
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):592-3. PubMed ID: 17082801
    [No Abstract]   [Full Text] [Related]  

  • 49. Pharmacotherapeutic approaches for Prader-Willi Syndrome.
    Jerome L
    Can J Psychiatry; 1989 Nov; 34(8):845-6. PubMed ID: 2819652
    [No Abstract]   [Full Text] [Related]  

  • 50. Prader-Willi-Labhart syndrome: orthopaedic complications.
    Donzelli O; Nanni ML; Terzi S; Iantorno DM
    Chir Organi Mov; 1993; 78(4):241-6. PubMed ID: 8149785
    [No Abstract]   [Full Text] [Related]  

  • 51. Urticaria pigmentosa in a child with Prader-Labhart-Willi syndrome.
    Fowler JF; Butler MG
    J Am Acad Dermatol; 1989 Jul; 21(1):147-8. PubMed ID: 2745768
    [No Abstract]   [Full Text] [Related]  

  • 52. Significant reduction of aggression with guanfacine extended release in an adolescent with Prader-Willi syndrome.
    Singh D; Kadakia N; Pinkhasov A
    J Child Adolesc Psychopharmacol; 2015 May; 25(4):376-7. PubMed ID: 25914925
    [No Abstract]   [Full Text] [Related]  

  • 53. Cerebral beta-endorphin levels in a woman with Prader-Labhart-Willi syndrome.
    Pasi A; Mehraein P; Gramsch C; Jehle A; Briner J; Häni M; Külling P; Hauri R; Messiha FS
    Physiol Behav; 1989 Jul; 46(1):17-8. PubMed ID: 2530599
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liraglutide in Prader Willi-Syndrome: The Importance of Placebo-Controlled Studies.
    Aguilar Salinas CA; Gómez Díaz RA
    J Clin Endocrinol Metab; 2023 Jun; 108(7):e493-e494. PubMed ID: 36638011
    [No Abstract]   [Full Text] [Related]  

  • 55. Growth hormone secretion in the Prader-Labhart-Willi syndrome.
    Hasen J; Wu RH
    Fertil Steril; 1982 Oct; 38(4):499. PubMed ID: 6749558
    [No Abstract]   [Full Text] [Related]  

  • 56. [Developmental psychopharmacology: example of Prader-Willi syndrome].
    Consoli A; Tauber M; Cohen D
    Rev Prat; 2020 May; 70(5):507-508. PubMed ID: 33058635
    [No Abstract]   [Full Text] [Related]  

  • 57. Fenfluramine.
    Br Med J; 1967 Jul; 3(5558):159. PubMed ID: 6028106
    [No Abstract]   [Full Text] [Related]  

  • 58. [Ponderal Retard].
    de Longraye J
    Soins; 1981 Jan; 26(2):45-6. PubMed ID: 6910217
    [No Abstract]   [Full Text] [Related]  

  • 59. [Clinical study of a new anorexigenic].
    Plauchu M; Arnaud P; Pousset G
    Lyon Med; 1968 Jan; 219(2):111-7. PubMed ID: 5664949
    [No Abstract]   [Full Text] [Related]  

  • 60. Pharmacotherapy of eating and behavioral problems.
    Jerome L
    J Am Acad Child Adolesc Psychiatry; 1991 Sep; 30(5):854. PubMed ID: 1938813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.